References

1. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ III. Risk factors for deep-vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med. 2000;160(6):809-815.
2. Gerotziafas GT, Samama MM. Prophylaxis of venous thromboembolism in medical patients. Curr Opin Pulm Med. 2004;10(5):356-365.
3. Heit JA, Cohen AT, Anderson FA Jr; VTE Impact Assessment Group. Estimated annual number of incident and recurrent, non-fatal and fatal venous thromboembolism (VTE) events in the US. Presented at: American Society of Hematology, 47th Annual Meeting and Exposition; December 10-13, 2005; Atlanta, GA. Poster #68.
4. The Joint Commission. Accreditation program: hospital. National Patient Safety Goals. The Joint Commission website. http://www.jointcommission.org/NR/rdonlyres/31666E86-E7F4-423E-9BE8-F05BD1CB0AA8/0/HAP_NPSG.pdf. Accessed August 6, 2009.
5. The National Quality Forum (NQF). Safe practices for better healthcare 2009 update: a consensus report. Washington, DC: National Quality Forum; 2009.
6. U.S. Department of Health and Human Services. The Surgeon General’s call to action to prevent deep vein thrombosis and pulmonary embolism: 2008. Office of the Surgeon General website. http://www.surgeongeneral.gov/topics/deepvein/calltoaction/call-to-action-on-dvt-2008.pdf.
   September 15, 2008. Accessed August 19, 2009.
7. National Heart, Lung, and Blood Institute. Diseases and conditions index. What is pulmonary embolism? NHLBI website. http://www.nhlbi.nih.gov/health/dci/Diseases/pe/pe_what.html. Accessed June 23, 2009.
8. Amin A, Stemkowski S, Lin J, Yang G. Thromboprophylaxis rates in US medical centers: success or failure? J Thromb Haemost. 2007;5(8):1610-1616.
9. Surgical Care Improvement Project. SCIP process and outcome measures. QualityNet website. http://www.qualitynet.org/dcs/ContentServer?cid=1136495755695&pagename=Medqic%2FOtherResource%2FOtherResourcesTemplate&c=OtherResource. Accessed August 19, 2009.
10. Centers for Medicare & Medicaid Services and Agency for Healthcare Research and Quality. Hospital CAHPS^® (HCAHPS^®) Fact Sheet. CMS website. http://www.cms.hhs.gov/HospitalQualityInits/downloads/ HospitalHCAHPSFactSheet200512.pdf. December 1, 2005. Accessed August 19, 2009.
11. U.S. Department of Health and Human Services. Quality measures. Hospital Compare website. http://www.hospitalcompare.hhs.gov/Hospital/Static/About-HospQuality.asp?dest=NAV%7CHome%7CAbout%7CQualityMeasures%7CWelcome-SearchOptions#WhatAreHospitalQM. Accessed
    August 19, 2009.
12. Tapson VF, Decousus H, Pini M, et al. Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients; findings from the International Medical Prevention Registry on Venous Thromboembolism. Chest. 2007;132(3):936-945.
13. The Joint Commission. Approved: more options for hospital core measures. Joint Commission Perspectives. 2009;29(4):4-6.
14. Centers for Medicare & Medicaid Services. Medicare programs; changes to the hospital inpatient prospective payment systems and fiscal year 2009 rates. Fed Regist. 2008;73(161):48433-49084.
15. Wheeler HB. Diagnosis of deep vein thrombosis: review of clinical evaluation and impedance plethysmography. Am J Surg. 1985;150(4A):7-13.
16. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008;133(6 suppl):
    381S-453S.
17. Wheeler AP. Identifying at-risk patients for venous thromboembolism prophylaxis. In: Merli GJ, ed. Thrombosis Prophylaxis of Venous Thromboembolism. Bridgewater, NJ: Elsevier; 2005:9-21.
18. Caprini JA, Arcelus JI. State-of-the-art venous thromboembolism prophylaxis. Scope Phlebol Lymphol. 2001;8(1):228-240.
19. Spencer FA, Lessard D, Emery C, Reed G, Goldberg RJ. Venous thromboembolism in the outpatient setting. Arch Intern Med. 2007;167(14):1471-1475.
20. Maynard G, Jenkins I, Stone S, et al. Prevention of hospital-acquired venous thromboembolism: prospective validation of a VTE risk assessment model and protocol. In: 2008 Abstracts: Research, Innovations, Clinical Vignettes Competition. San Diego, CA: Society of Hospital Medicine; 2008. Abstract 52.
21. Maynard G, Jenkins I, Stone S, et al. Optimizing prevention of hospital-acquired venous thromboembolism: prospective validation of a VTE risk assessment model. Presented at: Society of Hospital Medicine (SHM) Annual Meeting; April 3-5, 2008; San Diego, CA. Poster.
22. MacDougall DA, Feliu AL, Boccuzzi SJ, Lin J. Economic burden of deep-vein thrombosis, pulmonary embolism, and post-thrombotic syndrome. Am J Health-Syst Pharm. 2006;63(suppl 6):S5-S15.
23. Spyropoulos AC, Lin J. Direct medical costs of venous thromboembolism and subsequent hospital readmission rates: an administrative claims analysis from 30 managed care organizations. J Manag Care Pharm. 2007;13(6):475-486.
24. The Coalition to Prevent Deep-Vein Thrombosis. Coalition information. Coalition website. http://www.preventdvt.org/coalitionInfo/about.aspx. Accessed August 26, 2009.